MarketPeel
Insider Trading Intelligence
OS

Otello Stampacchia

REPL
DIRECTOR · REPLIMUNE GROUP, INC. · CIK 0001361712
FILING MIX · LIFETIME24%/76%
BUYS
11
SELLS
35
TOTAL VALUE
$31.13M
COMPANIES
4
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
4,688,980
AVG SELL PX
$30.83
TRADE KIND
SHOWING 46 / 46
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
29 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Otello Stampacchia, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d29+55.17%-2.74%+0.16%-2.90%-0.82%
14d29+65.52%-6.49%+0.40%-6.89%-7.97%
30d29+82.76%-12.47%+0.61%-13.08%-16.70%
60d29+82.76%-19.65%+0.79%-20.43%-22.49%
90d29+96.55%-32.63%-0.57%-32.06%-39.40%
180d29+82.76%-36.86%-2.71%-34.16%-41.63%
1y29(1 pending)+85.71%-35.99%-5.23%-30.77%-28.64%
2y29(1 pending)+100.00%-52.85%+4.91%-57.75%-61.34%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
REPL · 4,673,380 shares · as of Mar 16, 2022
01,331,8272,663,6543,995,4805,327,30720212022SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 35 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IMA
IMAGENEBIO, INC.
PURCHASEGRANT
Stock grant
15,60015,600Jun 16, 2026Jun 18, 2026View →
IMA
IMAGENEBIO, INC.
SALE
17,5200Jul 25, 2025Jul 30, 2025View →
IMA
IMAGENEBIO, INC.
PURCHASE
267,556$29.90$8.00M454,982Jul 25, 2025Jul 30, 2025View →
IMA
IMAGENEBIO, INC.
PURCHASE
379379Jul 25, 2025Jul 30, 2025View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASE
287,2131,703,078Nov 7, 2023Nov 9, 2023View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASE
454,545$11.00$5.00M2,157,623Nov 7, 2023Nov 9, 2023View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
2,615,5330Nov 7, 2023Nov 9, 2023View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASE
1,415,8651,415,865Nov 7, 2023Nov 9, 2023View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
14,999,9990Nov 7, 2023Nov 9, 2023View →
REPL
REPLIMUNE GROUP, INC.
SALE
6,238$15.31$95.5K4,712,142Mar 16, 2022Mar 16, 2022View →
REPL
REPLIMUNE GROUP, INC.
SALE
38,762$15.55$602.7K4,673,380Mar 16, 2022Mar 16, 2022View →
REPL
REPLIMUNE GROUP, INC.
SALE
45,000$15.64$703.8K4,718,380Mar 15, 2022Mar 16, 2022View →
REPL
REPLIMUNE GROUP, INC.
SALE
16,50016,500Mar 14, 2022Mar 16, 2022View →
REPL
REPLIMUNE GROUP, INC.
PURCHASE
16,500$9.78$161.4K4,779,880Mar 14, 2022Mar 16, 2022View →
REPL
REPLIMUNE GROUP, INC.
SALE
16,500$15.42$254.4K4,763,380Mar 14, 2022Mar 16, 2022View →
REPL
REPLIMUNE GROUP, INC.
SALE
10,162$34.70$352.6K4,763,380Nov 22, 2021Nov 23, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
34,845$34.54$1.20M4,773,959Nov 19, 2021Nov 23, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
417$34.80$14.5K4,773,542Nov 19, 2021Nov 23, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
2,441$33.50$81.8K4,808,804Nov 18, 2021Nov 18, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
2,441$33.50$81.8K4,808,804Nov 18, 2021Nov 18, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
153$33.50$5.1K4,811,245Nov 16, 2021Nov 18, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
153$33.50$5.1K4,811,245Nov 16, 2021Nov 18, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
782$33.66$26.3K4,811,398Nov 15, 2021Nov 16, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
23,235$33.66$782.1K4,812,180Nov 12, 2021Nov 16, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
18,279$33.61$614.4K4,835,415Nov 11, 2021Nov 12, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
11$33.50$3694,853,694Nov 10, 2021Nov 12, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
7,537$33.73$254.2K4,853,705Nov 9, 2021Nov 10, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
3,817$33.53$128.0K4,861,242Nov 8, 2021Nov 10, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
5,790$33.50$194.0K4,865,059Nov 5, 2021Nov 8, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
25,225$33.58$847.1K4,870,849Nov 4, 2021Nov 8, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
12,171$33.58$408.7K4,896,074Sep 23, 2021Sep 27, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
78,998$32.88$2.60M4,923,710Sep 17, 2021Sep 20, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
15,465$33.71$521.3K4,908,245Sep 17, 2021Sep 20, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
5,537$32.55$180.2K5,002,708Sep 16, 2021Sep 20, 2021View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
16,50016,500Apr 1, 2021Apr 5, 2021View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
500,000$10.00$5.00M28,212,373Feb 10, 2021Feb 12, 2021View →
NUVB
NUVATION BIO INC.
PURCHASE
8,130,09727,712,373Feb 10, 2021Feb 12, 2021View →
NUVB
NUVATION BIO INC.
SALE
8,130,0970Feb 10, 2021Feb 12, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
5,249$45.00$236.2K5,141,321Feb 8, 2021Feb 10, 2020View →
REPL
REPLIMUNE GROUP, INC.
SALE
26,957$45.34$1.22M5,287,075Jan 26, 2021Jan 28, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
3,393$46.04$156.2K5,283,682Jan 26, 2021Jan 28, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
8,090$45.05$364.5K5,317,301Jan 22, 2021Jan 26, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
3,269$45.03$147.2K5,314,032Jan 22, 2021Jan 26, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
1,916$45.19$86.6K5,325,391Jan 15, 2021Jan 19, 2021View →
REPL
REPLIMUNE GROUP, INC.
SALE
17,664$45.09$796.5K5,327,307Jan 14, 2021Jan 19, 2021View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
16,50016,500Apr 1, 2020Apr 3, 2020View →
Other insiders · REPL
Loading peer insiders…
About this filer
CIK 0001361712
ROLE
Director
PRIMARY
REPL
COMPANIES
4
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001361712DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback